BNC Korea Co., Ltd. (256840.KQ)

KRW 4160.0

(-1.42%)

Long Term Debt Summary of BNC Korea Co., Ltd.

  • BNC Korea Co., Ltd.'s latest annual long term debt in 2023 was 301.69 Million KRW , down -97.57% from previous year.
  • BNC Korea Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 4 Billion KRW , down 0.0% from previous quarter.
  • BNC Korea Co., Ltd. reported annual long term debt of 12.41 Billion KRW in 2022, down -65.45% from previous year.
  • BNC Korea Co., Ltd. reported annual long term debt of 35.92 Billion KRW in 2021, up 452.73% from previous year.
  • BNC Korea Co., Ltd. reported quarterly long term debt of 438.94 Million KRW for 2024 Q1, down 0.0% from previous quarter.
  • BNC Korea Co., Ltd. reported quarterly long term debt of 12.69 Billion KRW for 2023 Q1, up 2.3% from previous quarter.

Annual Long Term Debt Chart of BNC Korea Co., Ltd. (2023 - 2016)

Historical Annual Long Term Debt of BNC Korea Co., Ltd. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 301.69 Million KRW -97.57%
2022 12.41 Billion KRW -65.45%
2021 35.92 Billion KRW 452.73%
2020 6.5 Billion KRW -46.46%
2019 12.13 Billion KRW 140.99%
2018 5.03 Billion KRW 227.13%
2017 1.53 Billion KRW 2.15%
2016 1.5 Billion KRW 0.0%

Peer Long Term Debt Comparison of BNC Korea Co., Ltd.

Name Long Term Debt Long Term Debt Difference
HLB Pharmaceutical Co., Ltd 988.75 Million KRW 69.488%
CMG Pharmaceutical Co., Ltd. 19.06 Billion KRW 98.417%
Celltrion Pharm, Inc. 4.33 Billion KRW 93.038%
Huons Global Co., Ltd. 66.94 Billion KRW 99.549%
DongKook Pharmaceutical Co., Ltd. 18.74 Billion KRW 98.391%
Enzychem Lifesciences Corporation 1.02 Billion KRW 70.567%
Humedix Co., Ltd. 1.75 Billion KRW 82.813%
Boditech Med Inc. 2.09 Billion KRW 85.633%
EuBiologics Co., Ltd. 2.8 Billion KRW 89.225%
FutureChem Co.,Ltd 2.61 Billion KRW 88.484%
Huons Co., Ltd. 58.35 Billion KRW 99.483%
AptaBio Therapeutics Inc. 13.56 Billion KRW 97.777%